Relevance of CD38 expression on CD8 T cells to evaluate antiretroviral therapy response in HIV-1-infected youths

Scandinavian Journal of Immunology

Volumn 71, Issue 1, 2009, Pages 45-51

  Rosso, R ^a   Fenoglio, D ^b   Terranova, M P ^c   Lantieri, F ^b   Risso, D ^b   Pontali, E ^d   Setti, M ^b   Cossarizza, A ^e   Ravetti, J L ^a   Viscoli, C ^a   Kunkl, A ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c G GASLINI INSTITUTE   (Italy)

^d GALLIERA HOSPITAL   (Italy)

^e UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD38 ANTIGEN; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADOLESCENT; ADULT; ANTIGEN EXPRESSION; ARTICLE; CD8+ T LYMPHOCYTE; CHILD; CLINICAL ARTICLE; DRUG RESPONSE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LYMPHOCYTE PROLIFERATION; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; VIRUS LOAD;

EID: 72349094042     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2009.02345.x     Document Type: Article

References (33)

1. Savarino A, Bottarel F, Malavasi F, Dianzani U. Role of CD38 in HIV-1 infection: an epiphenomenon of T-cell activation or an active player in virus/host interactions? AIDS 2000 14 : 1079 1089.
2. Zidovec Lepej S, Vince A, Dakovic Rode O, Remenar A, Jeren T. Increased numbers of CD38 molecules on bright CD8+ T lymphocytes in infectious mononucleosis caused by Epstein-Barr virus infection. Clin Exp Immunol 2003 133 : 384 390.
3. De Martino M, Tovo PA, Balducci M et al. Reduction in mortality with availability of antiretroviral therapy for children with perinatal HIV-1 infection. JAMA 2000 284 : 190 197.
4. Sharland M, di Zub GC, Ramos JT, Blanche S, Gibb DM PENTA Steering Committee. PENTA guidelines for the use of antiretroviral therapy in paediatric HIV infection. HIV Med 2002 3 : 215 226.
5. Working Group on Antiretroviral Therapy and Medical Management of HIV-Infected Children. Guidelines for the use of antiretroviral agents in pediatric HIV infection. February 23, 2009 1 145. Available at http://aidsinfo.nih.gov/ContentFiles/PediatricGuidelines.pdf. accessed (March 1, 2009).
6. Panel on Antiretroviral Guidelines for Adult and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. November 3, 2008 1 146. Available at http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdfaccessed (March 1, 2009).
7. Resino S, Bellón MJ, Gurbindo D et al. Viral load and CD4+ T lymphocyte response to highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children: an observational study. Clin Infect Dis 2003 37 : 1216 1225.
8. Stone KD, Feldman HA, Huisman C, Howlett C, Jabara HH, Bonilla FA. Analysis of in vitro lymphocyte proliferation as a screening tool for cellular immunodeficiency. Clin Immunol 2009 131 : 41 9.
9. Resino S, Bellón JM, Gurbindo MD, Muñoz-Fernández MA. CD38 expression in CD8+ T cells predicts virological failure in HIV type 1-infected children receiving antiretroviral therapy. Clin Infect Dis 2004 38 : 412 417.
10. Glencross DK, Janossy G, Coetzee LM et al. CD8/CD38 activation yields important clinical information of effective antiretroviral therapy: findings from the first year of the CIPRA-SA cohort. Cytometry B Clin Cytom 2008 74 : S131 40.
11. Anselmi A, Vendrame D, Rampon O, Giaquinto C, Zanchetta M, De Rossi A. Immune reconstitution in human immunodeficiency type 1-infected children with different virological responses to anti-retroviral therapy. Clin Exp Immunol 2007 150 : 442 450.
12. Onlamoon N, Tabprasit S, Suwanagool S, Louisirirotchanakul S, Ansari AA, Pattanapanyasat K. Studies on the potential use of CD38 expression as a marker for the efficacy of anti-retroviral therapy in HIV-1-infected patients in Thailand. Virol 2005 341 : 238 247.
13. Valdez H. Immune restoration after treatment of HIV-1 infection with highly active antiretroviral therapy (HAART). AIDS Rev 2002 4 : 157 164.
14. Elrefaei M, McElroy MD, Preas CP et al. Central memory CD4+T cell responses in chronic HIV infection are not restored by antiretroviral therapy. J Immunol 2004 173 : 2184 2189.
15. Kolber MA, Saenz MO, Tanner TJ, Arheart KL, Pahwa S, Liu H. Intensification of a suppressive HAART regimen increases CD4 counts and decreases CD8+ T-cell activation. Clin Immunol 2008 126 : 315 321.
16. Tuaillon E, Al Tabaa Y, Baillat V et al. Close association of CD8+/CD38 bright with HIV-1 replication and complex relationship with CD4+ T-cell count. Cytometry B Clin Cytom. 2009 76B : 249 260.
17. Kolber MA. CD38+CD8+ T-cells negatively correlate with CD4 central memory cells in virally suppressed HIV-1-infected individuals. AIDS 2008 22 : 1937 1941.
18. McCloskey TW, Cavaliere T, Bakshi S et al. Immunophenotyping of T lymphocytes by three-color flow cytometry in healthy newborns, children and adults. Clin Immunol Immunopathol 1997 84 : 46 55.
19. Centers for Disease Control and Prevention. 1997 revised guidelines for performing CD4+ T-cell determinations in persons infected with human immunodeficiency virus (HIV). MMWR Recomm Rep 1997 46 (RR-2 1 29.
20. Protocol for CD38 fluorescence intensity quantitation available at http://cyto.mednet.ucla.edu/
21. Kraan J, Gratama JW, Keeney M, D'Hautcourt JL. Setting up and calibration of a flow cytometer for multicolor immunophenotyping. J Biol Regul Homeost Agents 2003 17 : 223 233.
22. TM beads. Cytometry 1998 33 : 206 212.
23. Li Pira G, Fenoglio D, Bottone L et al. Preservation of clonal heterogeneity of the Pneumocystis carinii-specific CD4 T cell repertoire in HIV infected, asymptomatic individuals. Clin Exp Immunol 2002 128 : 155 162.
24. Kunkl A, Mortara L, Valle MT et al. Recognition of antigenic clusters of Candida albicans by T lymphocytes from human immunodeficiency virus-infected persons. J Infect Dis 1998 178 : 488 496.
25. Li Pira G, Bottone L, Fenoglio D et al. Analysis of the antigen specific T cell repertoires in HIV infection. Immunol Lett 2001 79 : 85 91.
26. Viganó A, Saresella M, Rusconi S, Ferrante P, Clerici M. Expression of CD38 on CD8 T cells predicts maintenance of high viraemia in HAART-treated HIV-1-infected children. Highly active antiretroviral therapy. Lancet 1998 352 : 1905 1906.
27. Tilling R, Kinloch S, Goh LE et al. Quest Study Group. Parallel decline of CD8+/CD38++ T cells and viraemia in response to quadruple highly active antiretroviral therapy in primary HIV infection. AIDS 2002 16 : 589 596.
28. Steel A, Cox AE, Shamji MH et al. HIV-1 viral replication below 50 copies/ml in patients on antiretroviral therapy is not associated with CD8+ T-cell activation. Antivir Ther 2007 12 : 971 975.
29. Steel A, John L, Shamji MH et al. CD38 expression on CD8 T cells has a weak association with CD4 T-cell recovery and is a poor marker of viral replication in HIV-1-infected patients on antiretroviral therapy. HIV Med 2008 9 : 118 125.
30. Ondoa P, Koblavi-Dème S, Borget MY, Nolan ML, Nkengasong JN, Kestens L. Assessment of CD8 T cell immune activation markers to monitor response to antiretroviral therapy among HIV-1 infected patients in Côte d'Ivoire. Clin Exp Immunol 2005 140 : 138 148.
31. De Rossi A, Walker AS, Klein N, De Forni D, King D, Gibb DM. Increased thymic output after initiation of antiretroviral therapy in human immunodeficiency virus type 1-infected children in the Paediatric European Network for Treatment of AIDS (PENTA) 5 Trial. J Infect Dis 2002 186 : 312 320. (Pubitemid 34816314)
32. Borkowsky W, Stanley K, Douglas SD et al. Immunologic response to combination nucleoside analogue plus protease inhibitor therapy in stable antiretroviral therapy-experienced human immunodeficiency virus-infected children. J Infect Dis 2000 182 : 96 103.
33. Essajee SM, Kim M, Gonzalez C et al. Immunologic and virologic responses to HAART in severely immunocompromised HIV-1-infected children. AIDS 1999 13 : 2523 2532.